Skip to main content
. 2023 Oct 9;203(2):235–243. doi: 10.1007/s10549-023-07129-1

Table 3.

In utilization cohort: multivariable logistic regression analyzing the association between receipt of NAC and clinical factors among patients with breast cancer (BCBaSe 3.0/NKBC, 2008–2019)

OR 95% CI 95% CI P-value
Low High
Female versus male 1.135 0.606 2.128 0.692
Age 0.967 0.963 0.970  < 0.001
Educational Level
 High (≧13 years) Ref
 Intermediate (10–12 years) 0.732 0.628 0.853  < 0.001
 Low (≦9 years) 0.890 0.801 0.989 0.030
Household Income
 Q4 (High) Ref
 Q3 0.708 0.624 0.803  < 0.001
 Q2 0.676 0.591 0.773  < 0.001
 Q1 (Low) 0.585 0.504 0.680  < 0.001
Healtcare regions
 Northern Ref
 Stockholm Gotland 2.707 2.197 3.335  < 0.001
 Uppsala-Örebro 0.826 0.657 1.038 0.101
 South 2.119 1.698 2.645  < 0.001
 Southeast 1.664 1.313 2.108  < 0.001
 Western 0.813 0.647 1.023 0.077
Clinical T stage
 T1-2 Ref
 T3-4 4.151 1.782 9.667  < 0.001
Clinical N stage
 cN- Ref
 cN +  1.888 1.039 3.432 0.037
Histological grade
 I Ref
 II 4.305 3.587 5.167  < 0.001
 III 4.049 3.575 4.586  < 0.001
Subtype according to IHC
 Luminal Ref
 HER2-positive 3.077 2.714 3.489  < 0.001
 Triple-negative 5.876 5.077 6.802  < 0.001
Morphological type
 Ductal Ref
 Lobular 0.778 0.669 0.906  < 0.001
 Other 0.667 0.530 0.838  < 0.001

The multivariate models were complete case analyses

Bold text indicates a statistically significant difference with a p-value less than 0.05